BDBM220380 US9290488, ZA01
SMILES: NC1(CN(C1)c1nc2ccccc2n([C@@H]2C[C@@H]3CCC[C@H](C2)N3[C@H]2C[C@@H]3C[C@H](C2)CCCC3)c1=O)C(O)=O
InChI Key: InChIKey=IIQBWWKHQCWLSI-SSIAJPCRSA-N
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM220380 (US9290488, ZA01) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 0.220 | -13.2 | n/a | n/a | n/a | n/a | n/a | 7.4 | 25 |
Purdue Pharma L.P. US Patent | Assay Description Radioligand binding assays (screening and dose-displacement) used 0.1 nM [3H]-nociceptin (NEN; 87.7 Ci/mmole) with 10-20 μg membrane protein in a ... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Opioid growth factor receptor-like protein 1 (Homo sapiens (Human)) | BDBM220380 (US9290488, ZA01) | KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >2.00E+4 | n/a | n/a | 7.4 | 25 |
Purdue Pharma L.P. US Patent | Assay Description ORL-1 membrane solution was prepared by sequentially adding final concentrations of 0.066 μg/μL ORL-1 membrane protein, 10 μg/mL saponin, 3 ... | US Patent US9290488 (2016) BindingDB Entry DOI: 10.7270/Q2GF0SCW | |||||||||||
More data for this Ligand-Target Pair |